Application 091020

Type
ANDA
Sponsor
NAVINTA LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001FAMOTIDINEFAMOTIDINEFOR SUSPENSION;ORAL40MG/5MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16714-244FAMOTIDINEFAMOTIDINENorthstar Rx LLCANDACurrent
16714-244FAMOTIDINEFAMOTIDINENorthstar Rx LLCANDACurrent
16714-244FAMOTIDINEFAMOTIDINENorthstar Rx LLCANDACurrent
68382-444FAMOTIDINEfamotidineZydus Pharmaceuticals USA Inc.ANDACurrent
68382-444FamotidineFamotidineZydus Pharmaceuticals USA IncANDACurrent
68382-444FAMOTIDINEfamotidineZydus Pharmaceuticals USA Inc.ANDACurrent
68475-400famotidinefamotidineNavinta LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
9312ORIG2010-06-02